AMNEAL PHARMACEUTICALS, INC. (AMRX) Operating margin 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) operating margin by fiscal year — reported operating income divided by reported revenue.
13.1%FY2025 · since FY2016: 28.0% → 13.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.1% | +4.1 pp |
| FY2024 | 8.9% | +0.4 pp |
| FY2023 | 8.5% | +12.8 pp |
| FY2022 | -4.3% | -11.6 pp |
| FY2021 | 7.3% | +2.7 pp |
| FY2020 | 4.6% | +19.9 pp |
| FY2019 | -15.3% | -14.1 pp |
| FY2018 | -1.2% | -24.9 pp |
| FY2017 | 23.7% | -4.3 pp |
| FY2016 | 28.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice